Monoclonal Antibodies Market
Monoclonal Antibodies Market - Global Industry Assessment & Forecast
#
Pages:
146
Base Year:
2022
Jun - 2022
Format:
Report Code:
VMR-1673
Segments Covered
By
Source Murine, Chimeric, Humanized, Human
-
By
Indication Cancer, Autoimmune Diseases, Inflammatory Diseases, Infectious Diseases, Others
-
By
End User Hospitals, Research Institutes, Others
-
By
Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
 Base Year:
|
2022 |
| Forecast
Years:
|
2023 - 2030 |
 Historical
Years:
|
2017 - 2021 |
 Revenue
2022: |
USD 111.93 Billion |
 Revenue 2030:
|
USD 186.67 Billion |
 Revenue CAGR
(2023 - 2030): |
6.60% |
Fastest Growing Region (2023 -
2030)
|
Asia Pacific |
Largest Region (2022):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Monoclonal Antibodies Market Segment Analysis
- Monoclonal Antibodies Source Outlook (Revenue, USD Million, 2018 - 2030)
- Murine
- Chimeric
- Humanized
- Human
- Monoclonal Antibodies Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Cancer
- Autoimmune Diseases
- Inflammatory Diseases
- Infectious Diseases
- Others
- Monoclonal Antibodies End User Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
- Research Institutes
- Others
-
Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
- North America
-
North America Monoclonal Antibodies Market, by Source
- Murine
- Chimeric
- Humanized
- Human
-
North America Monoclonal Antibodies Market, by Indication
- Cancer
- Autoimmune Diseases
- Inflammatory Diseases
- Infectious Diseases
- Others
-
North America Monoclonal Antibodies Market, by End User
- Hospitals
- Research Institutes
- Others
- U.S.
- U.S. Monoclonal Antibodies Market, by Source
- Murine
- Chimeric
- Humanized
- Human
- U.S. Monoclonal Antibodies Market, by Indication
- Cancer
- Autoimmune Diseases
- Inflammatory Diseases
- Infectious Diseases
- Others
- U.S. Monoclonal Antibodies Market, by End User
- Hospitals
- Research Institutes
- Others
- U.S. Monoclonal Antibodies Market, by Source
- Canada
- Canada Monoclonal Antibodies Market, by Source
- Murine
- Chimeric
- Humanized
- Human
- Canada Monoclonal Antibodies Market, by Indication
- Cancer
- Autoimmune Diseases
- Inflammatory Diseases
- Infectious Diseases
- Others
- Canada Monoclonal Antibodies Market, by End User
- Hospitals
- Research Institutes
- Others
- Canada Monoclonal Antibodies Market, by Source
-
Mexico
- Mexico Monoclonal Antibodies Market, by Source
- Murine
- Chimeric
- Humanized
- Human
- Mexico Monoclonal Antibodies Market, by Indication
- Cancer
- Autoimmune Diseases
- Inflammatory Diseases
- Infectious Diseases
- Others
- Mexico Monoclonal Antibodies Market, by End User
- Hospitals
- Research Institutes
- Others
- Mexico Monoclonal Antibodies Market, by Source
-
North America Monoclonal Antibodies Market, by Source
- Europe
-
Europe Monoclonal Antibodies Market, by Source
- Murine
- Chimeric
- Humanized
- Human
-
Europe Monoclonal Antibodies Market, by Indication
- Cancer
- Autoimmune Diseases
- Inflammatory Diseases
- Infectious Diseases
- Others
-
Europe Monoclonal Antibodies Market, by End User
- Hospitals
- Research Institutes
- Others
- U. K.
- U.K. Monoclonal Antibodies Market, by Source
- Murine
- Chimeric
- Humanized
- Human
- U.K. Monoclonal Antibodies Market, by Indication
- Cancer
- Autoimmune Diseases
- Inflammatory Diseases
- Infectious Diseases
- Others
- U.K. Monoclonal Antibodies Market, by End User
- Hospitals
- Research Institutes
- Others
- U.K. Monoclonal Antibodies Market, by Source
- France
- France Monoclonal Antibodies Market, by Source
- Murine
- Chimeric
- Humanized
- Human
- France Monoclonal Antibodies Market, by Indication
- Cancer
- Autoimmune Diseases
- Inflammatory Diseases
- Infectious Diseases
- Others
- France Monoclonal Antibodies Market, by End User
- Hospitals
- Research Institutes
- Others
- France Monoclonal Antibodies Market, by Source
-
Germany
- Germany Monoclonal Antibodies Market, by Source
- Murine
- Chimeric
- Humanized
- Human
- Germany Monoclonal Antibodies Market, by Indication
- Cancer
- Autoimmune Diseases
- Inflammatory Diseases
- Infectious Diseases
- Others
- Germany Monoclonal Antibodies Market, by End User
- Hospitals
- Research Institutes
- Others
- Germany Monoclonal Antibodies Market, by Source
-
Italy
- Italy Monoclonal Antibodies Market, by Source
- Murine
- Chimeric
- Humanized
- Human
- Italy Monoclonal Antibodies Market, by Indication
- Cancer
- Autoimmune Diseases
- Inflammatory Diseases
- Infectious Diseases
- Others
- Italy Monoclonal Antibodies Market, by End User
- Hospitals
- Research Institutes
- Others
- Italy Monoclonal Antibodies Market, by Source
-
Spain
- Spain Monoclonal Antibodies Market, by Source
- Murine
- Chimeric
- Humanized
- Human
- Spain Monoclonal Antibodies Market, by Indication
- Cancer
- Autoimmune Diseases
- Inflammatory Diseases
- Infectious Diseases
- Others
- Spain Monoclonal Antibodies Market, by End User
- Hospitals
- Research Institutes
- Others
- Spain Monoclonal Antibodies Market, by Source
-
Rest of Europe
- Rest of Europe Monoclonal Antibodies Market, by Source
- Murine
- Chimeric
- Humanized
- Human
- Rest of Europe Monoclonal Antibodies Market, by Indication
- Cancer
- Autoimmune Diseases
- Inflammatory Diseases
- Infectious Diseases
- Others
- Rest of Europe Monoclonal Antibodies Market, by End User
- Hospitals
- Research Institutes
- Others
- Rest of Europe Monoclonal Antibodies Market, by Source
-
Europe Monoclonal Antibodies Market, by Source
- Asia Pacific
-
Asia Pacific Monoclonal Antibodies Market, by Source
- Murine
- Chimeric
- Humanized
- Human
-
Asia Pacific Monoclonal Antibodies Market, by Indication
- Cancer
- Autoimmune Diseases
- Inflammatory Diseases
- Infectious Diseases
- Others
-
Asia Pacific Monoclonal Antibodies Market, by End User
- Hospitals
- Research Institutes
- Others
- China
- China Monoclonal Antibodies Market, by Source
- Murine
- Chimeric
- Humanized
- Human
- China Monoclonal Antibodies Market, by Indication
- Cancer
- Autoimmune Diseases
- Inflammatory Diseases
- Infectious Diseases
- Others
- China Monoclonal Antibodies Market, by End User
- Hospitals
- Research Institutes
- Others
- China Monoclonal Antibodies Market, by Source
- Japan
- Japan Monoclonal Antibodies Market, by Source
- Murine
- Chimeric
- Humanized
- Human
- Japan Monoclonal Antibodies Market, by Indication
- Cancer
- Autoimmune Diseases
- Inflammatory Diseases
- Infectious Diseases
- Others
- Japan Monoclonal Antibodies Market, by End User
- Hospitals
- Research Institutes
- Others
- Japan Monoclonal Antibodies Market, by Source
-
Germany
- Germany Monoclonal Antibodies Market, by Source
- Murine
- Chimeric
- Humanized
- Human
- Germany Monoclonal Antibodies Market, by Indication
- Cancer
- Autoimmune Diseases
- Inflammatory Diseases
- Infectious Diseases
- Others
- Germany Monoclonal Antibodies Market, by End User
- Hospitals
- Research Institutes
- Others
- Germany Monoclonal Antibodies Market, by Source
-
India
- India Monoclonal Antibodies Market, by Source
- Murine
- Chimeric
- Humanized
- Human
- India Monoclonal Antibodies Market, by Indication
- Cancer
- Autoimmune Diseases
- Inflammatory Diseases
- Infectious Diseases
- Others
- India Monoclonal Antibodies Market, by End User
- Hospitals
- Research Institutes
- Others
- India Monoclonal Antibodies Market, by Source
-
South Korea
- South Korea Monoclonal Antibodies Market, by Source
- Murine
- Chimeric
- Humanized
- Human
- South Korea Monoclonal Antibodies Market, by Indication
- Cancer
- Autoimmune Diseases
- Inflammatory Diseases
- Infectious Diseases
- Others
- South Korea Monoclonal Antibodies Market, by End User
- Hospitals
- Research Institutes
- Others
- South Korea Monoclonal Antibodies Market, by Source
-
South East Asia
- South East Asia Monoclonal Antibodies Market, by Source
- Murine
- Chimeric
- Humanized
- Human
- South East Asia Monoclonal Antibodies Market, by Indication
- Cancer
- Autoimmune Diseases
- Inflammatory Diseases
- Infectious Diseases
- Others
- South East Asia Monoclonal Antibodies Market, by End User
- Hospitals
- Research Institutes
- Others
- South East Asia Monoclonal Antibodies Market, by Source
-
Rest of Asia Pacific
- Rest of Asia Pacific Monoclonal Antibodies Market, by Source
- Murine
- Chimeric
- Humanized
- Human
- Rest of Asia Pacific Monoclonal Antibodies Market, by Indication
- Cancer
- Autoimmune Diseases
- Inflammatory Diseases
- Infectious Diseases
- Others
- Rest of Asia Pacific Monoclonal Antibodies Market, by End User
- Hospitals
- Research Institutes
- Others
- Rest of Asia Pacific Monoclonal Antibodies Market, by Source
-
Asia Pacific Monoclonal Antibodies Market, by Source
- Latin America
-
Latin America Monoclonal Antibodies Market, by Source
- Murine
- Chimeric
- Humanized
- Human
-
Latin America Monoclonal Antibodies Market, by Indication
- Cancer
- Autoimmune Diseases
- Inflammatory Diseases
- Infectious Diseases
- Others
-
Latin America Monoclonal Antibodies Market, by End User
- Hospitals
- Research Institutes
- Others
- Brazil
- Brazil Monoclonal Antibodies Market, by Source
- Murine
- Chimeric
- Humanized
- Human
- Brazil Monoclonal Antibodies Market, by Indication
- Cancer
- Autoimmune Diseases
- Inflammatory Diseases
- Infectious Diseases
- Others
- Brazil Monoclonal Antibodies Market, by End User
- Hospitals
- Research Institutes
- Others
- Brazil Monoclonal Antibodies Market, by Source
- Argentina
- Argentina Monoclonal Antibodies Market, by Source
- Murine
- Chimeric
- Humanized
- Human
- Argentina Monoclonal Antibodies Market, by Indication
- Cancer
- Autoimmune Diseases
- Inflammatory Diseases
- Infectious Diseases
- Others
- Argentina Monoclonal Antibodies Market, by End User
- Hospitals
- Research Institutes
- Others
- Argentina Monoclonal Antibodies Market, by Source
-
Rest of Latin America
- Rest of Latin America Monoclonal Antibodies Market, by Source
- Murine
- Chimeric
- Humanized
- Human
- Rest of Latin America Monoclonal Antibodies Market, by Indication
- Cancer
- Autoimmune Diseases
- Inflammatory Diseases
- Infectious Diseases
- Others
- Rest of Latin America Monoclonal Antibodies Market, by End User
- Hospitals
- Research Institutes
- Others
- Rest of Latin America Monoclonal Antibodies Market, by Source
-
Latin America Monoclonal Antibodies Market, by Source
- Middle East & Africa
-
Middle East & Africa Monoclonal Antibodies Market, by Source
- Murine
- Chimeric
- Humanized
- Human
-
Middle East & Africa Monoclonal Antibodies Market, by Indication
- Cancer
- Autoimmune Diseases
- Inflammatory Diseases
- Infectious Diseases
- Others
-
Middle East & Africa Monoclonal Antibodies Market, by End User
- Hospitals
- Research Institutes
- Others
- GCC Countries
- GCC Countries Monoclonal Antibodies Market, by Source
- Murine
- Chimeric
- Humanized
- Human
- GCC Countries Monoclonal Antibodies Market, by Indication
- Cancer
- Autoimmune Diseases
- Inflammatory Diseases
- Infectious Diseases
- Others
- GCC Countries Monoclonal Antibodies Market, by End User
- Hospitals
- Research Institutes
- Others
- GCC Countries Monoclonal Antibodies Market, by Source
- South Africa
- South Africa Monoclonal Antibodies Market, by Source
- Murine
- Chimeric
- Humanized
- Human
- South Africa Monoclonal Antibodies Market, by Indication
- Cancer
- Autoimmune Diseases
- Inflammatory Diseases
- Infectious Diseases
- Others
- South Africa Monoclonal Antibodies Market, by End User
- Hospitals
- Research Institutes
- Others
- South Africa Monoclonal Antibodies Market, by Source
-
Rest of Middle East & Africa
- Rest of Middle East & Africa Monoclonal Antibodies Market, by Source
- Murine
- Chimeric
- Humanized
- Human
- Rest of Middle East & Africa Monoclonal Antibodies Market, by Indication
- Cancer
- Autoimmune Diseases
- Inflammatory Diseases
- Infectious Diseases
- Others
- Rest of Middle East & Africa Monoclonal Antibodies Market, by End User
- Hospitals
- Research Institutes
- Others
- Rest of Middle East & Africa Monoclonal Antibodies Market, by Source
-
Middle East & Africa Monoclonal Antibodies Market, by Source
- North America
Vantage Market
Research | 27-Jun-2022
FAQ
Frequently Asked Question
What is the global demand for Monoclonal Antibodies in terms of revenue?
-
The global Monoclonal Antibodies valued at USD 111.93 Billion in 2022 and is expected to reach USD 186.67 Billion in 2030 growing at a CAGR of 6.60%.
Which are the prominent players in the market?
-
The prominent players in the market are Abbott Laboratories, Amgen Inc., AstraZeneca PLC, Bayer AG, Eli Lilly, GlaxoSmithKline PLC, Johnson & Johnson, Merck & Co. Inc., Novartis, Pfizer.
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 6.60% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Monoclonal Antibodies include
- Rise in prevalence of various cancer types
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Monoclonal Antibodies in 2022.
